Literature DB >> 14501218

Oligodendrocyte precursor cells: reactive cells that inhibit axon growth and regeneration.

Zhi Jiang Chen1, Micheal Negra, Angela Levine, Yvonne Ughrin, Joel M Levine.   

Abstract

Oligodendrocyte precursor cells (OPCs) are a newly recognized glial component of the adult central nervous system of unknown function. Antibodies against the NG2 chondroitin sulfate proteoglycan have been useful tools to identify these cells in intact tissue. Here we review studies that show that OPCs react to several types of experimentally induced brain injury. Injury stimulates OPCs to re-enter the cell cycle, divide, and accumulate at the site of damage. OPCs, together with microglia and astrocytes, form the glial scar. Glial scars are thought to inhibit or prevent axonal regeneration and reactive OPCs contribute to this inhibition by producing growth-inhibiting chondroitin sulfate proteoglycans, particularly NG2. In developing animals, NG2 is found in areas, such as the perinotochordal mesenchyme, that are avoided by growing motor and sensory axons. Within the developing CNS, NG2-expressing cells surround the developing optic chiasm and tract and separate it from the overlying diencephalon. Thus, NG2-expressing cells are well positioned to inhibit axonal growth from developing as well as regenerating neurons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14501218     DOI: 10.1023/a:1025791614468

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  30 in total

1.  How the primate fornix is affected by age.

Authors:  Alan Peters; Claire Sethares; Mark B Moss
Journal:  J Comp Neurol       Date:  2010-10-01       Impact factor: 3.215

2.  Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat.

Authors:  Niklas Marklund; Carl T Fulp; Saori Shimizu; Rishi Puri; Asenia McMillan; Stephen M Strittmatter; Tracy K McIntosh
Journal:  Exp Neurol       Date:  2006-01       Impact factor: 5.330

Review 3.  NG2: a component of the glial scar that inhibits axon growth.

Authors:  Andrew M Tan; Weibing Zhang; Joel M Levine
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

Review 4.  Synantocytes: the fifth element.

Authors:  Arthur M Butt; Niki Hamilton; Paul Hubbard; Mari Pugh; Merdol Ibrahim
Journal:  J Anat       Date:  2005-12       Impact factor: 2.610

5.  Fate of endogenous stem/progenitor cells following spinal cord injury.

Authors:  Laura L Horky; Francesco Galimi; Fred H Gage; Philip J Horner
Journal:  J Comp Neurol       Date:  2006-10-01       Impact factor: 3.215

Review 6.  Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia.

Authors:  Jerry Silver; Martin E Schwab; Phillip G Popovich
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-04       Impact factor: 10.005

7.  An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature.

Authors:  Kaisa Lehti; Edward Allen; Henning Birkedal-Hansen; Kenn Holmbeck; Yasuhiro Miyake; Tae-Hwa Chun; Stephen J Weiss
Journal:  Genes Dev       Date:  2005-04-01       Impact factor: 11.361

8.  Astrogliosis: a target for intervention in intracerebral hemorrhage?

Authors:  Sangeetha Sukumari-Ramesh; Cargill H Alleyne; Krishnan M Dhandapani
Journal:  Transl Stroke Res       Date:  2012-04-14       Impact factor: 6.829

9.  Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury.

Authors:  Sarah A Busch; Kevin P Horn; Fernando X Cuascut; Alicia L Hawthorne; Lianhua Bai; Robert H Miller; Jerry Silver
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

10.  Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain.

Authors:  Annalisa Buffo; Inmaculada Rite; Pratibha Tripathi; Alexandra Lepier; Dilek Colak; Ana-Paula Horn; Tetsuji Mori; Magdalena Götz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.